11.07.2012
- The European Union's executive is due to propose new rules next week to make it easier for drug companies and researchers to carry out cross-border clinical trials, in a bid to cut...
20.06.2012
- Institutional investors doubt that treatments for Alzheimer's disease being developed by Pfizer and Eli Lilly will achieve the main goals of their ongoing late-stage trials, but...
25.05.2012
- Clinilabs, an early phase and specialty CRO that provides clinical drug development services to the pharmaceutical industry, today announced that they have opened a second Phase I...
07.05.2012
- Swiss drugmaker Roche has ended efforts to develop a heart disease drug which some industry analysts had estimated could have achieved $10 billion in annual sales, after poor...
22.12.2011
- Three of Europe's biggest drugmakers - AstraZeneca, Novartis and Sanofi - reported product setbacks, underlining the difficulties of developing new medicines to make up for those...
21.09.2011
- Eli Lilly announced findings from a prospectively designed observational study that resulted in new ways to increase minority participation in clinical trials. As part of Lilly's...
19.04.2010
- Oracle said on Friday it agreed to spend $685 million to buy Phase Forward, the top maker of programs that help drugmakers run clinical trials, in Oracle's biggest software...